For instance, the results of Heller and Eoh et al. identified HOXA2 as potential prognostic markers and therapeutic targets for non-small cell lung cancer and cervical cancer patients [36, 37]. This evidence concerns the gene HOXA2 and non-small cell lung carcinoma.